I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2015-04, Vol.50 (4), p.607-609
Hauptverfasser:	Yamamoto, H, Uchida, N, Matsuno, N, Kon, A, Nishida, A, Ota, H, Ikebe, T, Nakano, N, Ishiwata, K, Araoka, H, Takagi, S, Tsuji, M, Asano-Mori, Y, Yamamoto, G, Izutsu, K, Masuoka, K, Wake, A, Yoneyama, A, Makino, S, Taniguchi, S
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/283/1897 692/699/1541/1990/283/1897 Adult Aged Bone marrow Bone marrow transplantation Busulfan - administration & dosage Care and treatment Cell Biology Cord blood Cord Blood Stem Cell Transplantation Disease-Free Survival Dosage and administration Female Fludarabine Health aspects Health risks Hematologic diseases Hematologic Diseases - mortality Hematologic Diseases - therapy Hematological diseases Hematology Humans Internal Medicine letter-to-the-editor Male Medicine Medicine & Public Health Melphalan Melphalan - administration & dosage Middle Aged Public Health Risk Factors Stem cell transplantation Stem Cells Survival Rate Transplantation Transplantation Conditioning Vidarabine - administration & dosage Vidarabine - analogs & derivatives Whole-Body Irradiation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!